StockMacro
Menu

Chemours

$10.88 -51% in 6 monthsMarket cap $1.6B

CC on XNYS, Materials, The Chemours Company, job postings

Measures activity, not value. Not investment advice.

Shares fell 49% in six months, and the 12 month loss was $154M despite 3.0% quarterly revenue growth.

  • BadShort interest 9.7% of shares, 6.8 days to cover
  • WatchCapital spending up 24% to $51M last quarter

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

The Chemours Co is a provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, paints and coatings, plastics, transportation, semiconductor, and others. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.

Industry
Chemicals & allied products (Materials)
Employees
5,700
Website
chemours.com
Listed
NYSE, US
Last results
2 Nov 2026
Next results
expected around 18 Feb 2027 (an estimate: a year ago it reported on 19 Feb 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $1.5B, net income $196.0M.
Quarter to 31 Dec 2021: revenue $1.6B, net income $233.0MQuarter to 31 Dec 2021: revenue $1.6B, net income $233.0MQuarter to 31 Mar 2022: revenue $1.8B, net income $234.0MQuarter to 31 Mar 2022: revenue $1.8B, net income $234.0MQuarter to 30 Jun 2022: revenue $1.9B, net income $201.0MQuarter to 30 Jun 2022: revenue $1.9B, net income $201.0MQuarter to 30 Sep 2022: revenue $1.8B, net income $240.0MQuarter to 30 Sep 2022: revenue $1.8B, net income $240.0MQuarter to 31 Dec 2022: revenue $1.3B, net income -$97.0MQuarter to 31 Dec 2022: revenue $1.3B, net income -$97.0MQuarter to 31 Mar 2023: revenue $1.5B, net income $145.0MQuarter to 31 Mar 2023: revenue $1.5B, net income $145.0MQuarter to 30 Jun 2023: revenue $1.6B, net income -$376.0MQuarter to 30 Jun 2023: revenue $1.6B, net income -$376.0MQuarter to 30 Sep 2023: revenue $1.5B, net income $20.0MQuarter to 30 Sep 2023: revenue $1.5B, net income $20.0MQuarter to 31 Dec 2023: revenue $1.4B, net income -$18.0MQuarter to 31 Dec 2023: revenue $1.4B, net income -$18.0MQuarter to 31 Mar 2024: revenue $1.4B, net income $52.0MQuarter to 31 Mar 2024: revenue $1.4B, net income $52.0MQuarter to 30 Jun 2024: revenue $1.5B, net income $70.0MQuarter to 30 Jun 2024: revenue $1.5B, net income $70.0MQuarter to 30 Sep 2024: revenue $1.5B, net income -$27.0MQuarter to 30 Sep 2024: revenue $1.5B, net income -$27.0MQuarter to 31 Dec 2024: revenue $1.4B, net income -$8.0MQuarter to 31 Dec 2024: revenue $1.4B, net income -$8.0MQuarter to 31 Mar 2025: revenue $1.4B, net income -$4.0MQuarter to 31 Mar 2025: revenue $1.4B, net income -$4.0MQuarter to 30 Jun 2025: revenue $1.6B, net income -$381.0MQuarter to 30 Jun 2025: revenue $1.6B, net income -$381.0MQuarter to 30 Sep 2025: revenue $1.5B, net income $60.0MQuarter to 30 Sep 2025: revenue $1.5B, net income $60.0MQuarter to 31 Dec 2025: revenue $1.3B, net income -$47.0MQuarter to 31 Dec 2025: revenue $1.3B, net income -$47.0MQuarter to 31 Mar 2026: revenue $1.4B, net income -$29.0MQuarter to 31 Mar 2026: revenue $1.4B, net income -$29.0MQuarter to 30 Jun 2026: revenue $1.6B, net income -$274.0MQuarter to 30 Jun 2026: revenue $1.6B, net income -$274.0MQuarter to 30 Sep 2026: revenue $1.5B, net income $196.0MQuarter to 30 Sep 2026: revenue $1.5B, net income $196.0M
31 Dec 2021RevenueNet incomeNet losstallest bar $1.9B30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$1.5B$196.0M
30 Jun 2026$1.6B-$274.0M
31 Mar 2026$1.4B-$29.0M
31 Dec 2025$1.3B-$47.0M
30 Sep 2025$1.5B$60.0M
30 Jun 2025$1.6B-$381.0M
31 Mar 2025$1.4B-$4.0M
31 Dec 2024$1.4B-$8.0M
30 Sep 2024$1.5B-$27.0M
30 Jun 2024$1.5B$70.0M
31 Mar 2024$1.4B$52.0M
31 Dec 2023$1.4B-$18.0M
30 Sep 2023$1.5B$20.0M
30 Jun 2023$1.6B-$376.0M
31 Mar 2023$1.5B$145.0M
31 Dec 2022$1.3B-$97.0M
30 Sep 2022$1.8B$240.0M
30 Jun 2022$1.9B$201.0M
31 Mar 2022$1.8B$234.0M
31 Dec 2021$1.6B$233.0M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $5.8B $5.8B
Revenue growthRevenue of the last 12 months compared with the 12 months before. +0.1% -0.3%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. -$154.0M -$350.0M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). -$1.02 -$2.33
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. 15.1% 17.3% 22.0%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. – – -2.3%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. -2.6% -6.0% 1.3%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. -71.8% 1.7%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. $211.0M -$12.0M
CashCash, cash equivalents and short-term investments on the latest balance sheet. $698.0M $613.0M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $3.8B $4.2B
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). $3.1B $3.5B
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 24.7 0.81
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $1.03
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. loss 29.8
P/SPrice to sales: market cap divided by revenue of the last 12 months. 0.28 1.1
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. 0.82 1.4
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 10.6 2.5
Dividend yieldDividends per share declared in the latest fiscal year divided by the share price. 4.7% 2.0%

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
ChemoursCC (this company) $1.6Bloss0.28+0.1%-2.6%
OlinOLN $1.7Bloss0.26-0.7%-3.3%
IngevityNGVT $1.8B30.41.6-6.5%5.3%
HuntsmanHUN $1.5Bloss0.26-4.7%-5.8%
InnospecIOSP $1.9B13.30.99+4.7%7.5%
EcovystECVT $977.5M27.11.0+45%3.7%

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

–

No data for this company

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

-4.1%

443 13F filers vs 462

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

87%

130.6M shares held by 13F filers (30 Sep 2026) of 150.5M outstanding (27 Oct 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

9.7%

14.5M shares sold short (30 Oct 2026) of 150.5M outstanding (27 Oct 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

6.8

14.5M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-2.1%

14.9M shares sold short in the report before, 14.5M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

58%

58% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 51%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

–

We do not track this company's careers site yet.

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

We do not track this company's careers site yet.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

+3.0%

$1.5B vs $1.5B (quarter ended 30 Sep 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

+24%

$51.0M vs $41.0M (quarter ended 30 Sep 2026)

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

–

No data for this company

Lobbying What the company reported spending on federal lobbying over the last four quarters.

$1.5M

4 quarters, $

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

20

20 articles in the last 7 days; its usual week has 3 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

6.7×

20 articles in the last 7 days; its usual week has 3.

Price $10.88 on 20 Nov 2026, +3.8% over 12 months (12-month range $10.48 to $27.94)

  • Sharp change
  • 8-K and other filings
  • Lobbying filing
Insider net buying (open market). Insiders bought a net $489K in the last 12 months (the 12 months before: $301K).
Revenue per quarter. Revenue $1.5B in the latest quarter, +3.0% on a year earlier.
Capital spending per quarter. Capital spending $51.0M in the latest quarter, +24% on a year earlier.
Institutional holders (13F filers). 443 13F filers reported holding it in the latest 13F quarter, +11% on a year earlier.
Federal obligations. Federal obligations: $0 published in the last 12 months.
Lobbying spend. Lobbying spend: $1.5M published in the last 12 months, -24% on the 12 months before.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: h-1b/e-3 applications certified, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
18 Nov 20268-K and other filingsSVP, General Counsel & Corporate Secretary Kristine M. Wellman to retire; Amy M. Rocklin succeeds her Jan 4, 2027
18 Nov 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
12 Aug 2026Sharp changeClustered insider buying: clustered insider buying (5 independent filers, 5 filing(s) in 30 days, value_usd total 408K)
30 Apr 20268-K and other filingsDirector or officer change
30 Apr 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
31 Oct 20258-K and other filingsDirector or officer change
2 Sep 2025Sharp changeShort interest spike: short interest spike, 18.2M vs usual 7.9M (2025-08-15); 2.9x the same period a year earlier
29 Aug 20258-K and other filingsDirector or officer change
29 Aug 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
14 Aug 2025Sharp changeMany funds opening a new position: many funds opening a new position, 69 vs usual 51 (2025-06-30); 1.3x the same period a year earlier
12 Aug 2025Sharp changeShort interest spike: short interest spike, 14.9M vs usual 7.8M (2025-07-31); 2.9x the same period a year earlier
29 Jul 2025Sharp changeShort interest spike: short interest spike, 16.0M vs usual 7.7M (2025-07-15); 3.2x the same period a year earlier
1 Jul 2025Sharp changeShort interest spike: short interest spike, 14.3M vs usual 7.4M (2025-06-13); 2.6x the same period a year earlier
17 Jun 2025Sharp changeShort interest spike: short interest spike, 12.7M vs usual 7.3M (2025-05-30); 2.4x the same period a year earlier
3 Jun 2025Sharp changeShort interest spike: short interest spike, 13.3M vs usual 7.3M (2025-05-15); 2.3x the same period a year earlier
13 May 2025Sharp changeShort interest spike: short interest spike, 12.7M vs usual 7.3M (2025-04-30); 2.2x the same period a year earlier
29 Apr 2025Sharp changeShort interest spike: short interest spike, 13.2M vs usual 7.3M (2025-04-15); 2.5x the same period a year earlier
21 Apr 2025Sharp changeLobbying on a new issue: lobbying on a new issue: CPI (2025-03-31)
15 Apr 2025Sharp changeShort interest spike: short interest spike, 12.9M vs usual 7.2M (2025-03-31); 2.6x the same period a year earlier
10 Mar 20258-K and other filingsDirector or officer change
18 Feb 20258-K and other filingsDirector or officer change
11 Feb 20258-K and other filingsDirector or officer change
7 Jan 20258-K and other filingsDirector or officer change
7 Jan 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
19 Nov 2024Sharp changeShort interest spike: short interest spike, 7.7M vs usual 5.3M (2024-10-31); 1.3x the same period a year earlier
29 Oct 2024Sharp changeShort interest spike: short interest spike, 8.0M vs usual 5.3M (2024-10-15); 1.5x the same period a year earlier
15 Oct 2024Sharp changeShort interest spike: short interest spike, 7.8M vs usual 5.2M (2024-09-30); 1.6x the same period a year earlier
1 Oct 2024Sharp changeShort interest spike: short interest spike, 7.3M vs usual 5.2M (2024-09-13); 1.5x the same period a year earlier
25 Jul 20248-K and other filingsDirector or officer change
23 Jul 2024Sharp changeLobbying spend jump: lobbying spend jump, 500K vs usual 295K (2024-06-30); 1.8x the same period a year earlier
13 Jun 20248-K and other filingsDirector or officer change
5 Jun 20248-K and other filingsDirector or officer change
25 Apr 20248-K and other filingsDirector or officer change
2 Apr 2024Sharp changeQuarterly capital spending jump: quarterly capital spending jump, 135.0M vs usual 77.5M (2023-12-31); 2.0x the same period a year earlier
25 Mar 20248-K and other filingsDirector or officer change
18 Mar 20248-K and other filingsDelisting notice or listing transfer
29 Feb 20248-K and other filingsReport will be filed late
29 Feb 20248-K and other filingsDirector or officer change
16 Feb 20248-K and other filingsDirector or officer change
23 Jan 2024Sharp changeLobbying on a new issue: lobbying on a new issue: SCI (2023-12-31)
22 Nov 20238-K and other filingsDirector or officer change
22 Nov 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
16 Oct 2023Lobbying filinglobbying engagement terminated (THORN RUN PARTNERS)
28 Jul 20238-K and other filingsAsset write-down (impairment)
28 Jul 20238-K and other filingsRestructuring costs announced
20 Jul 2023Lobbying filingnew lobbying registration (BOSE PUBLIC AFFAIRS GROUP)
19 Jul 2023Lobbying filinglobbying engagement terminated (CGCN GROUP, LLC)
6 Jun 20238-K and other filingsDirector or officer change
18 May 20238-K and other filingsDirector or officer change
23 Mar 20238-K and other filingsDirector or officer change
16 Mar 20238-K and other filingsDirector or officer change
20 Jan 2023Sharp changeLobbying on a new issue: lobbying on a new issue: NAT (2022-12-31)
22 Dec 20228-K and other filingsDirector or officer change
22 Dec 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
22 Aug 20228-K and other filingsDirector or officer change
22 Aug 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
10 May 2022Sharp changeQuarterly capital spending jump: quarterly capital spending jump, 106.0M vs usual 64.0M (2022-03-31); 1.8x the same period a year earlier
20 Apr 2022Sharp changeLobbying on a new issue: lobbying on a new issue: MAN (2022-03-31)
15 Feb 2022Lobbying filingnew lobbying registration (THORN RUN PARTNERS)
9 Feb 20228-K and other filingsDirector or officer change
9 Feb 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
19 Jan 2022Lobbying filinglobbying engagement terminated (MCALLISTER & QUINN, LLC)
Insider net buying (open market)
Month from 1 Dec 2021: -$4.8M published
Month from 1 May 2022: -$18.7M published
Month from 1 Jun 2022: -$965K published
Month from 1 Mar 2023: -$983K published
Month from 1 Jun 2023: -$205K published
Month from 1 Aug 2024: -$52K published
Month from 1 Nov 2024: -$155K published
Month from 1 May 2025: $50K published
Month from 1 Jun 2025: $201K published
Month from 1 Aug 2025: $49K published
Month from 1 Aug 2026: $489K published
Revenue per quarter
Quarter ended 31 Dec 2021: $1.6B, +18% on a year earlier; public on 12 Feb 2022
Quarter ended 31 Mar 2022: $1.8B, +23% on a year earlier; public on 4 May 2022
Quarter ended 30 Jun 2022: $1.9B, +16% on a year earlier; public on 2 Aug 2022
Quarter ended 30 Sep 2022: $1.8B, +5.8% on a year earlier; public on 27 Oct 2022
Quarter ended 31 Dec 2022: $1.3B, -15% on a year earlier; public on 28 Mar 2024
Quarter ended 31 Mar 2023: $1.5B, -13% on a year earlier; public on 29 Apr 2023
Quarter ended 30 Jun 2023: $1.6B, -14% on a year earlier; public on 29 Jul 2023
Quarter ended 30 Sep 2023: $1.5B, -16% on a year earlier; public on 28 Oct 2023
Quarter ended 31 Dec 2023: $1.4B, +1.7% on a year earlier; public on 28 Mar 2024
Quarter ended 31 Mar 2024: $1.4B, -12% on a year earlier; public on 1 May 2024
Quarter ended 30 Jun 2024: $1.5B, -6.4% on a year earlier; public on 2 Aug 2024
Quarter ended 30 Sep 2024: $1.5B, +0.9% on a year earlier; public on 5 Nov 2024
Quarter ended 31 Dec 2024: $1.4B, -0.1% on a year earlier; public on 19 Feb 2025
Quarter ended 31 Mar 2025: $1.4B, +1.3% on a year earlier; public on 7 May 2025
Quarter ended 30 Jun 2025: $1.6B, +5.0% on a year earlier; public on 6 Aug 2025
Quarter ended 30 Sep 2025: $1.5B, -0.4% on a year earlier; public on 7 Nov 2025
Quarter ended 31 Dec 2025: $1.3B, -2.2% on a year earlier; public on 25 Feb 2026
Quarter ended 31 Mar 2026: $1.4B, +1.0% on a year earlier; public on 6 May 2026
Quarter ended 30 Jun 2026: $1.6B, -1.5% on a year earlier; public on 6 Aug 2026
Quarter ended 30 Sep 2026: $1.5B, +3.0% on a year earlier; public on 6 Nov 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $83.0M, +57% on a year earlier; public on 12 Feb 2022
Quarter ended 31 Mar 2022: $106.0M, +77% on a year earlier; public on 4 May 2022
Quarter ended 30 Jun 2022: $62.0M, -7.5% on a year earlier; public on 2 Aug 2022
Quarter ended 30 Sep 2022: $72.0M, +7.5% on a year earlier; public on 27 Oct 2022
Quarter ended 31 Dec 2022: $67.0M, -19% on a year earlier; public on 11 Feb 2023
Quarter ended 31 Mar 2023: $91.0M, -14% on a year earlier; public on 29 Apr 2023
Quarter ended 30 Jun 2023: $58.0M, -6.5% on a year earlier; public on 29 Jul 2023
Quarter ended 30 Sep 2023: $86.0M, +19% on a year earlier; public on 28 Oct 2023
Quarter ended 31 Dec 2023: $135.0M, +101% on a year earlier; public on 28 Mar 2024
Quarter ended 31 Mar 2024: $102.0M, +12% on a year earlier; public on 1 May 2024
Quarter ended 30 Jun 2024: $73.0M, +26% on a year earlier; public on 2 Aug 2024
Quarter ended 30 Sep 2024: $76.0M, -12% on a year earlier; public on 5 Nov 2024
Quarter ended 31 Dec 2024: $109.0M, -19% on a year earlier; public on 19 Feb 2025
Quarter ended 31 Mar 2025: $84.0M, -18% on a year earlier; public on 7 May 2025
Quarter ended 30 Jun 2025: $43.0M, -41% on a year earlier; public on 6 Aug 2025
Quarter ended 30 Sep 2025: $41.0M, -46% on a year earlier; public on 7 Nov 2025
Quarter ended 31 Dec 2025: $45.0M, -59% on a year earlier; public on 25 Feb 2026
Quarter ended 31 Mar 2026: $49.0M, -42% on a year earlier; public on 6 May 2026
Quarter ended 30 Jun 2026: $44.0M, +2.3% on a year earlier; public on 6 Aug 2026
Quarter ended 30 Sep 2026: $51.0M, +24% on a year earlier; public on 6 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 444; public on 14 Feb 2022
31 Mar 2022 report: 451; public on 16 May 2022
30 Jun 2022 report: 477; public on 15 Aug 2022
30 Sep 2022 report: 437; public on 14 Nov 2022
31 Dec 2022 report: 430; public on 14 Feb 2023
31 Mar 2023 report: 445; public on 15 May 2023
30 Jun 2023 report: 425; public on 14 Aug 2023
30 Sep 2023 report: 412; public on 14 Nov 2023
31 Dec 2023 report: 433; public on 14 Feb 2024
31 Mar 2024 report: 411; public on 15 May 2024
30 Jun 2024 report: 410; public on 14 Aug 2024
30 Sep 2024 report: 395; public on 14 Nov 2024
31 Dec 2024 report: 426; public on 14 Feb 2025
31 Mar 2025 report: 401; public on 15 May 2025
30 Jun 2025 report: 417; public on 14 Aug 2025
30 Sep 2025 report: 398; public on 14 Nov 2025
31 Dec 2025 report: 411; public on 17 Feb 2026
31 Mar 2026 report: 436; public on 15 May 2026
30 Jun 2026 report: 462; public on 14 Aug 2026
30 Sep 2026 report: 443; public on 16 Nov 2026
Federal obligations
Month from 1 Sep 2022: $0 published
Lobbying spend
Quarter from 1 Jan 2022: $270K published
Quarter from 1 Apr 2022: $340K published
Quarter from 1 Jul 2022: $250K published
Quarter from 1 Oct 2022: $280K published
Quarter from 1 Jan 2023: $320K published
Quarter from 1 Apr 2023: $340K published
Quarter from 1 Jul 2023: $280K published
Quarter from 1 Oct 2023: $310K published
Quarter from 1 Jan 2024: $260K published
Quarter from 1 Apr 2024: $340K published
Quarter from 1 Jul 2024: $500K published
Quarter from 1 Oct 2024: $460K published
Quarter from 1 Jan 2025: $320K published
Quarter from 1 Apr 2025: $530K published
Quarter from 1 Jul 2025: $760K published
Quarter from 1 Oct 2025: $340K published
Quarter from 1 Jan 2026: $300K published
Quarter from 1 Apr 2026: $510K published
Quarter from 1 Jul 2026: $340K published
Quarter from 1 Oct 2026: $330K published

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is insider open-market buying (USD, Form 4) at $81K (13 Aug 2026), 3.3× its normal reading; higher than 79% of its own history.
  • Clustered insider buying: had 5 insiders buy $408K of its shares on the open market within 30 days (5 filings) Public on 12 Aug 2026.
  • Revenue per quarter: Revenue $1.5B in the latest quarter, +3.0% on a year earlier.
  • Capital spending per quarter: Capital spending $51.0M in the latest quarter, +24% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

Insider trades

All 88 insider trades

No trades in the last 90 days; the latest was filed 13 Aug 2026. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
13 Aug 2026Calderon Gerardo FamiliarSee RemarksBuy1,935$15.53$30KForm 4
13 Aug 2026Denise DignamChief Executive OfficerBuy3,378$14.95$51KForm 4
11 Aug 2026Mary B CranstonDirectorBuy6,000$15.83$95KForm 4
11 Aug 2026Alister CowanDirectorBuy13,000$15.62$203KForm 4
11 Aug 2026Michael Robert FoleySee RemarksBuy1,934$15.51$30KForm 4
11 Aug 2026Joseph T. MartinkoSee RemarksBuy1,940$15.47$30KForm 4
10 Aug 2026Shane HostetterChief Financial OfficerBuy3,350$14.94$50KForm 4
12 Aug 2025Denise DignamPresident & CEOBuy4,068$12.06$49KForm 4

443 institutions reported shares at the end of Q3 2026, 87% of the shares outstanding; 58 opened a position, 78 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
BlackRock, Inc.22.5M15.0%$305.6M-764K-3.3%
Vanguard Portfolio Management LLC10.9M7.25%$148.1M+347K+3.3%
Vanguard Capital Management LLC6.8M4.51%$92.2M+8,424+0.1%
State Street Corp6.1M4.04%$82.5M-32K-0.5%
JPMorgan Chase & Co5.8M3.83%$80.2M+1.6M+37%
Cooper Creek Partners Management LLC5.6M3.72%+1.9M+51%
Ameriprise Financial Inc4.6M3.07%$62.7M-302K-6.1%
Geode Capital Management, LLC3.8M2.51%$51.2M-47K-1.2%
D. E. Shaw & Co., Inc.3.5M2.33%$47.5M+634K+22%
Goldman Sachs Group Inc2.8M1.89%$38.5M+286K+11%

Company events

All 68 company events

In 12 months: 4 major agreements, 2 director or officer changes. Results releases and routine reports are left out.

FiledWhat happenedSource
18 Nov 2026SVP, General Counsel & Corporate Secretary Kristine M. Wellman to retire; Amy M. Rocklin succeeds her Jan 4, 20278-K
10 Sep 2026Signed a major agreement8-K
24 Jun 2026Signed a major agreement8-K
29 Apr 2026Director or officer changeSame filing: shareholder vote results8-K
12 Mar 2026Signed a major agreementSame filing: took on new debt8-K
16 Jan 2026Signed a major agreement8-K
31 Oct 2025Director or officer change8-K
15 Oct 2025Signed a major agreementSame filing: took on new debt8-K

Reported lobbying spend: $330K in Q3 2026, $340K in Q2 2026. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.

DateChangeLobbying firmIssueSource
1 Jul 2023NewBose Public Affairs Groupfor The Chemours CompanyIssues relating to a secure domestic supply of critical chemicals and materialsCHM, EnvironmentFiling
30 Jun 2023EndedThorn Run Partnersfor The Chemours CompanyFY24 House and Senate Defense Appropriations Bills. Department of Commerce CHIPS Funding Areas.Budget, ManufacturingFiling
1 Jun 2023EndedCGCN Group, LLCfor The Chemours CompanyIssues related to PFAS, GHG emissions standards and mobile air-conditioning; PFAS legislative proposals; Issues related to clean energy tax credits, environmental clean up funding.; Issues related to PFAS, GHG emissions standards and mobile air-conditioning.; Issues related to PFAS, clean energy R&D.; Issues related to clean energy tax credits, environmental clean up funding.Environment, CHM, Defense, TaxationFiling
1 Jan 2022NewThorn Run Partnersfor The Chemours CompanyDefense Appropriations, S.1260, U.S. Innovation & Competition Act, H.R. 4521, America COMPETES Act, H.R. 4432/S.3023 House Defense Appropriations Bill and FY22 Senate Defense Appropriations BillManufacturing, BudgetFiling
31 Dec 2021EndedMcallister & Quinn, LLCfor ChemoursDepartment of Defense and Department of Energy funding for innovative technologiesBudgetFiling
1 Oct 2021NewMcallister & Quinn, LLCfor ChemoursDepartment of Defense and Department of Energy funding for innovative technologiesEnergy, Defense, BudgetFiling
31 Oct 2019EndedAcg Advocacyfor The Chemours CompanyIssues related to Montreal Protocol.CHMFiling
1 Feb 2019NewAcg Advocacyfor The Chemours CompanyIssues related to Montreal Protocol.CHMFiling

The 5 newest of 226 articles that name the company.

Timeline

Several things at once

Two or more unrelated kinds of records unusual within 30 days

21 Apr 2025confirmed

Confirmed across sources Institutional holdings and Lobbying and Short interest and volume

Chemours (CC): lobbying on a new issue; it also saw 69 13F filers open a new position in the quarter ended 30 Jun 2025, 1.3× the same quarter last year; and it had 18.2M shares sold short in the 15 Aug 2025 report, 2.9× the same report last year. Three unrelated kinds of activity within 140 days.

  • Short interest and volume: Short interest spike, became public on 10 Apr 2025
  • Lobbying: Lobbying on a new issue, became public on 21 Apr 2025
  • Short interest and volume: Short interest spike, became public on 26 Apr 2025
  • Short interest and volume: Short interest spike, became public on 10 May 2025
  • Short interest and volume: Short interest spike, became public on 28 May 2025
  • Short interest and volume: Short interest spike, became public on 11 Jun 2025
  • Short interest and volume: Short interest spike, became public on 26 Jun 2025
  • Short interest and volume: Short interest spike, became public on 25 Jul 2025
  • Short interest and volume: Short interest spike, became public on 12 Aug 2025
  • Institutional holdings: Many funds opening a new position, became public on 14 Aug 2025
  • Short interest and volume: Short interest spike, became public on 27 Aug 2025
2023-06-30: 492023-09-30: 372023-12-31: 462024-03-31: 492024-06-30: 532024-09-30: 552024-12-31: 532025-03-31: 552025-06-30: 69
The quarter ended 30 Jun 2025 against the 8 quarters before it. this quarterearliernormal: 51
See the evidence (11 changes)

Short interest and volume: Short interest spike became public on 10 Apr 2025

Chemours had 12.9M shares sold short in the 31 Mar 2025 report, 2.6× the same report last year.

This period
12.9M (the 31 Mar 2025 report)
Normal report (median of 24 earlier)
7.2M
Typical spread (median absolute deviation)
880K
How far from its usual level
+4.3
Same report last year
4.9M
History used
2,649 days
2024-03-28: 4.9M2024-04-15: 5.3M2024-04-30: 5.7M2024-05-15: 5.9M2024-05-31: 5.4M2024-06-14: 5.5M2024-06-28: 5.1M2024-07-15: 5.1M2024-07-31: 5.2M2024-08-15: 6.2M2024-08-30: 6.5M2024-09-13: 7.3M2024-09-30: 7.8M2024-10-15: 8.0M2024-10-31: 7.7M2024-11-15: 7.3M2024-11-29: 7.3M2024-12-13: 7.2M2024-12-31: 7.4M2025-01-15: 7.3M2025-01-31: 7.3M2025-02-14: 7.7M2025-02-28: 8.8M2025-03-14: 10.5M2025-03-31: 12.9M
the 31 Mar 2025 report24 earlier reportsnormal: 7.2M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Lobbying: Lobbying on a new issue became public on 21 Apr 2025

Chemours lobbying on a new issue.

New
['CPI']
Rule
only points whose every posting (and value revision) is at or before as_of
Field
issue_codes
Metric
lobbying.filings_count
Point id
11559787

Short interest and volume: Short interest spike became public on 26 Apr 2025

Chemours had 13.2M shares sold short in the 15 Apr 2025 report, 2.5× the same report last year.

This period
13.2M (the 15 Apr 2025 report)
Normal report (median of 24 earlier)
7.3M
Typical spread (median absolute deviation)
925K
How far from its usual level
+4.3
Same report last year
5.3M
History used
2,664 days
2024-04-15: 5.3M2024-04-30: 5.7M2024-05-15: 5.9M2024-05-31: 5.4M2024-06-14: 5.5M2024-06-28: 5.1M2024-07-15: 5.1M2024-07-31: 5.2M2024-08-15: 6.2M2024-08-30: 6.5M2024-09-13: 7.3M2024-09-30: 7.8M2024-10-15: 8.0M2024-10-31: 7.7M2024-11-15: 7.3M2024-11-29: 7.3M2024-12-13: 7.2M2024-12-31: 7.4M2025-01-15: 7.3M2025-01-31: 7.3M2025-02-14: 7.7M2025-02-28: 8.8M2025-03-14: 10.5M2025-03-31: 12.9M2025-04-15: 13.2M
the 15 Apr 2025 report24 earlier reportsnormal: 7.3M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 10 May 2025

Chemours had 12.7M shares sold short in the 30 Apr 2025 report, 2.2× the same report last year.

This period
12.7M (the 30 Apr 2025 report)
Normal report (median of 24 earlier)
7.3M
Typical spread (median absolute deviation)
932K
How far from its usual level
+4.0
Same report last year
5.7M
History used
2,679 days
2024-04-30: 5.7M2024-05-15: 5.9M2024-05-31: 5.4M2024-06-14: 5.5M2024-06-28: 5.1M2024-07-15: 5.1M2024-07-31: 5.2M2024-08-15: 6.2M2024-08-30: 6.5M2024-09-13: 7.3M2024-09-30: 7.8M2024-10-15: 8.0M2024-10-31: 7.7M2024-11-15: 7.3M2024-11-29: 7.3M2024-12-13: 7.2M2024-12-31: 7.4M2025-01-15: 7.3M2025-01-31: 7.3M2025-02-14: 7.7M2025-02-28: 8.8M2025-03-14: 10.5M2025-03-31: 12.9M2025-04-15: 13.2M2025-04-30: 12.7M
the 30 Apr 2025 report24 earlier reportsnormal: 7.3M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 28 May 2025

Chemours had 13.3M shares sold short in the 15 May 2025 report, 2.3× the same report last year.

This period
13.3M (the 15 May 2025 report)
Normal report (median of 24 earlier)
7.3M
Typical spread (median absolute deviation)
942K
How far from its usual level
+4.3
Same report last year
5.9M
History used
2,694 days
2024-05-15: 5.9M2024-05-31: 5.4M2024-06-14: 5.5M2024-06-28: 5.1M2024-07-15: 5.1M2024-07-31: 5.2M2024-08-15: 6.2M2024-08-30: 6.5M2024-09-13: 7.3M2024-09-30: 7.8M2024-10-15: 8.0M2024-10-31: 7.7M2024-11-15: 7.3M2024-11-29: 7.3M2024-12-13: 7.2M2024-12-31: 7.4M2025-01-15: 7.3M2025-01-31: 7.3M2025-02-14: 7.7M2025-02-28: 8.8M2025-03-14: 10.5M2025-03-31: 12.9M2025-04-15: 13.2M2025-04-30: 12.7M2025-05-15: 13.3M
the 15 May 2025 report24 earlier reportsnormal: 7.3M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 11 Jun 2025

Chemours had 12.7M shares sold short in the 30 May 2025 report, 2.4× the same report last year.

This period
12.7M (the 30 May 2025 report)
Normal report (median of 24 earlier)
7.3M
Typical spread (median absolute deviation)
957K
How far from its usual level
+3.8
Same report last year
5.4M
History used
2,709 days
2024-05-31: 5.4M2024-06-14: 5.5M2024-06-28: 5.1M2024-07-15: 5.1M2024-07-31: 5.2M2024-08-15: 6.2M2024-08-30: 6.5M2024-09-13: 7.3M2024-09-30: 7.8M2024-10-15: 8.0M2024-10-31: 7.7M2024-11-15: 7.3M2024-11-29: 7.3M2024-12-13: 7.2M2024-12-31: 7.4M2025-01-15: 7.3M2025-01-31: 7.3M2025-02-14: 7.7M2025-02-28: 8.8M2025-03-14: 10.5M2025-03-31: 12.9M2025-04-15: 13.2M2025-04-30: 12.7M2025-05-15: 13.3M2025-05-30: 12.7M
the 30 May 2025 report24 earlier reportsnormal: 7.3M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 26 Jun 2025

Chemours had 14.3M shares sold short in the 13 Jun 2025 report, 2.6× the same report last year.

This period
14.3M (the 13 Jun 2025 report)
Normal report (median of 24 earlier)
7.4M
Typical spread (median absolute deviation)
1.0M
How far from its usual level
+4.7
Same report last year
5.5M
History used
2,723 days
2024-06-14: 5.5M2024-06-28: 5.1M2024-07-15: 5.1M2024-07-31: 5.2M2024-08-15: 6.2M2024-08-30: 6.5M2024-09-13: 7.3M2024-09-30: 7.8M2024-10-15: 8.0M2024-10-31: 7.7M2024-11-15: 7.3M2024-11-29: 7.3M2024-12-13: 7.2M2024-12-31: 7.4M2025-01-15: 7.3M2025-01-31: 7.3M2025-02-14: 7.7M2025-02-28: 8.8M2025-03-14: 10.5M2025-03-31: 12.9M2025-04-15: 13.2M2025-04-30: 12.7M2025-05-15: 13.3M2025-05-30: 12.7M2025-06-13: 14.3M
the 13 Jun 2025 report24 earlier reportsnormal: 7.4M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 25 Jul 2025

Chemours had 16.0M shares sold short in the 15 Jul 2025 report, 3.2× the same report last year.

This period
16.0M (the 15 Jul 2025 report)
Normal report (median of 24 earlier)
7.7M
Typical spread (median absolute deviation)
1.2M
How far from its usual level
+4.8
Same report last year
5.1M
History used
2,755 days
2024-07-15: 5.1M2024-07-31: 5.2M2024-08-15: 6.2M2024-08-30: 6.5M2024-09-13: 7.3M2024-09-30: 7.8M2024-10-15: 8.0M2024-10-31: 7.7M2024-11-15: 7.3M2024-11-29: 7.3M2024-12-13: 7.2M2024-12-31: 7.4M2025-01-15: 7.3M2025-01-31: 7.3M2025-02-14: 7.7M2025-02-28: 8.8M2025-03-14: 10.5M2025-03-31: 12.9M2025-04-15: 13.2M2025-04-30: 12.7M2025-05-15: 13.3M2025-05-30: 12.7M2025-06-13: 14.3M2025-06-30: 18.3M2025-07-15: 16.0M
the 15 Jul 2025 report24 earlier reportsnormal: 7.7M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 12 Aug 2025

Chemours had 14.9M shares sold short in the 31 Jul 2025 report, 2.9× the same report last year.

This period
14.9M (the 31 Jul 2025 report)
Normal report (median of 24 earlier)
7.8M
Typical spread (median absolute deviation)
1.2M
How far from its usual level
+4.1
Same report last year
5.2M
History used
2,771 days
2024-07-31: 5.2M2024-08-15: 6.2M2024-08-30: 6.5M2024-09-13: 7.3M2024-09-30: 7.8M2024-10-15: 8.0M2024-10-31: 7.7M2024-11-15: 7.3M2024-11-29: 7.3M2024-12-13: 7.2M2024-12-31: 7.4M2025-01-15: 7.3M2025-01-31: 7.3M2025-02-14: 7.7M2025-02-28: 8.8M2025-03-14: 10.5M2025-03-31: 12.9M2025-04-15: 13.2M2025-04-30: 12.7M2025-05-15: 13.3M2025-05-30: 12.7M2025-06-13: 14.3M2025-06-30: 18.3M2025-07-15: 16.0M2025-07-31: 14.9M
the 31 Jul 2025 report24 earlier reportsnormal: 7.8M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Institutional holdings: Many funds opening a new position became public on 14 Aug 2025

Chemours saw 69 13F filers open a new position in the quarter ended 30 Jun 2025, 1.3× the same quarter last year.

This period
69 (the quarter ended 30 Jun 2025)
Normal quarter (median of 8 earlier)
51
Typical spread (median absolute deviation)
3
How far from its usual level
+3.5
Same quarter last year
53
History used
3,653 days
2023-06-30: 492023-09-30: 372023-12-31: 462024-03-31: 492024-06-30: 532024-09-30: 552024-12-31: 532025-03-31: 552025-06-30: 69
the quarter ended 30 Jun 20258 earlier quartersnormal: 51

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

Check it at the source: SEC Form 13F data sets.

Short interest and volume: Short interest spike became public on 27 Aug 2025

Chemours had 18.2M shares sold short in the 15 Aug 2025 report, 2.9× the same report last year.

This period
18.2M (the 15 Aug 2025 report)
Normal report (median of 24 earlier)
7.9M
Typical spread (median absolute deviation)
1.2M
How far from its usual level
+5.9
Same report last year
6.2M
History used
2,786 days
2024-08-15: 6.2M2024-08-30: 6.5M2024-09-13: 7.3M2024-09-30: 7.8M2024-10-15: 8.0M2024-10-31: 7.7M2024-11-15: 7.3M2024-11-29: 7.3M2024-12-13: 7.2M2024-12-31: 7.4M2025-01-15: 7.3M2025-01-31: 7.3M2025-02-14: 7.7M2025-02-28: 8.8M2025-03-14: 10.5M2025-03-31: 12.9M2025-04-15: 13.2M2025-04-30: 12.7M2025-05-15: 13.3M2025-05-30: 12.7M2025-06-13: 14.3M2025-06-30: 18.3M2025-07-15: 16.0M2025-07-31: 14.9M2025-08-15: 18.2M
the 15 Aug 2025 report24 earlier reportsnormal: 7.9M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

10 May 2022confirmed

Confirmed across sources Filings + Financials and Lobbying

Chemours (CC): lobbying on a new issue, while it spent $106.0M on capital projects in the quarter ended 31 Mar 2022, 1.8× the same quarter last year. Two unrelated kinds of activity within 20 days.

  • Lobbying: Lobbying on a new issue, became public on 20 Apr 2022
  • Financials: Quarterly capital spending jump, became public on 10 May 2022
2020-03-31: $106.0M2020-06-30: $61.0M2020-09-30: $47.0M2020-12-31: $53.0M2021-03-31: $60.0M2021-06-30: $67.0M2021-09-30: $67.0M2021-12-31: $83.0M2022-03-31: $106.0M
The quarter ended 31 Mar 2022 against the 8 quarters before it. this quarterearliernormal: $64.0M
See the evidence (2 changes)

Lobbying: Lobbying on a new issue became public on 20 Apr 2022

Chemours lobbying on a new issue.

New
['MAN']
Rule
only points whose every posting (and value revision) is at or before as_of
Field
issue_codes
Metric
lobbying.filings_count
Point id
12632182

Financials: Quarterly capital spending jump became public on 10 May 2022

Chemours spent $106.0M on capital projects in the quarter ended 31 Mar 2022, 1.8× the same quarter last year.

This period
$106.0M (the quarter ended 31 Mar 2022)
Normal quarter (median of 8 earlier)
$64.0M
Typical spread (median absolute deviation)
$7.5M
How far from its usual level
+3.8
Same quarter last year
$60.0M
History used
2,739 days
2020-03-31: $106.0M2020-06-30: $61.0M2020-09-30: $47.0M2020-12-31: $53.0M2021-03-31: $60.0M2021-06-30: $67.0M2021-09-30: $67.0M2021-12-31: $83.0M2022-03-31: $106.0M
the quarter ended 31 Mar 20228 earlier quartersnormal: $64.0M

Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

Check it at the source: SEC EDGAR quarterly reports.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

21 May 2019confirmed

Confirmed across sources Insiders and Lobbying and Short interest and volume

Chemours (CC): reported $420K of lobbying spend for the quarter ended 31 Mar 2019, 2.1× the same quarter last year; it also had 3 insiders buy $295K of its shares on the open market within 30 days (3 filings); and it had 8.0M shares sold short in the 15 May 2019 report, 2.6× the same report last year. Three unrelated kinds of activity within 86 days.

  • Lobbying: Lobbying spend jump, became public on 22 Apr 2019
  • Insiders: Clustered insider buying, became public on 21 May 2019
  • Short interest and volume: Short interest spike, became public on 25 May 2019
  • Short interest and volume: Short interest spike, became public on 12 Jun 2019
  • Short interest and volume: Short interest spike, became public on 26 Jun 2019
  • Lobbying: Lobbying on a new issue, became public on 19 Jul 2019
2017-03-31: $100K2017-06-30: $270K2017-09-30: $100K2017-12-31: $120K2018-03-31: $200K2018-06-30: $130K2018-09-30: $100K2018-12-31: $170K2019-03-31: $420K
The quarter ended 31 Mar 2019 against the 8 quarters before it. this quarterearliernormal: $125K
See the evidence (6 changes)

Lobbying: Lobbying spend jump became public on 22 Apr 2019

Chemours reported $420K of lobbying spend for the quarter ended 31 Mar 2019, 2.1× the same quarter last year.

This period
$420K (the quarter ended 31 Mar 2019)
Normal quarter (median of 8 earlier)
$125K
Typical spread (median absolute deviation)
$25K
How far from its usual level
+8.0
Same quarter last year
$200K
History used
1,278 days
2017-03-31: $100K2017-06-30: $270K2017-09-30: $100K2017-12-31: $120K2018-03-31: $200K2018-06-30: $130K2018-09-30: $100K2018-12-31: $170K2019-03-31: $420K
the quarter ended 31 Mar 20198 earlier quartersnormal: $125K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least $100K.

Check it at the source: Senate/House lobbying disclosures (LDA).

Insiders: Clustered insider buying became public on 21 May 2019

Chemours had 3 insiders buy $295K of its shares on the open market within 30 days (3 filings).

Independent buyers
3
Purchase filings (Form 4, code P)
3
Total bought
$295K
Window
21 Apr 2019 to 21 May 2019

Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

Short interest and volume: Short interest spike became public on 25 May 2019

Chemours had 8.0M shares sold short in the 15 May 2019 report, 2.6× the same report last year.

This period
8.0M (the 15 May 2019 report)
Normal report (median of 24 earlier)
4.2M
Typical spread (median absolute deviation)
532K
How far from its usual level
+4.8
Same report last year
3.1M
History used
502 days
2018-05-15: 3.1M2018-05-31: 3.4M2018-06-15: 4.1M2018-06-29: 3.9M2018-07-13: 4.2M2018-07-31: 4.8M2018-08-15: 3.8M2018-08-31: 3.8M2018-09-14: 4.5M2018-09-28: 4.1M2018-10-15: 4.2M2018-10-31: 4.2M2018-11-15: 3.9M2018-11-30: 3.7M2018-12-14: 3.5M2018-12-31: 4.3M2019-01-15: 5.4M2019-01-31: 5.0M2019-02-15: 5.1M2019-02-28: 4.8M2019-03-15: 5.0M2019-03-29: 5.1M2019-04-15: 5.4M2019-04-30: 6.0M2019-05-15: 8.0M
the 15 May 2019 report24 earlier reportsnormal: 4.2M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 12 Jun 2019

Chemours had 7.4M shares sold short in the 31 May 2019 report, 2.2× the same report last year.

This period
7.4M (the 31 May 2019 report)
Normal report (median of 24 earlier)
4.3M
Typical spread (median absolute deviation)
527K
How far from its usual level
+3.9
Same report last year
3.4M
History used
518 days
2018-05-31: 3.4M2018-06-15: 4.1M2018-06-29: 3.9M2018-07-13: 4.2M2018-07-31: 4.8M2018-08-15: 3.8M2018-08-31: 3.8M2018-09-14: 4.5M2018-09-28: 4.1M2018-10-15: 4.2M2018-10-31: 4.2M2018-11-15: 3.9M2018-11-30: 3.7M2018-12-14: 3.5M2018-12-31: 4.3M2019-01-15: 5.4M2019-01-31: 5.0M2019-02-15: 5.1M2019-02-28: 4.8M2019-03-15: 5.0M2019-03-29: 5.1M2019-04-15: 5.4M2019-04-30: 6.0M2019-05-15: 8.0M2019-05-31: 7.4M
the 31 May 2019 report24 earlier reportsnormal: 4.3M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 26 Jun 2019

Chemours had 8.1M shares sold short in the 14 Jun 2019 report, 1.9× the same report last year.

This period
8.1M (the 14 Jun 2019 report)
Normal report (median of 24 earlier)
4.4M
Typical spread (median absolute deviation)
598K
How far from its usual level
+4.1
Same report last year
4.1M
History used
532 days
2018-06-15: 4.1M2018-06-29: 3.9M2018-07-13: 4.2M2018-07-31: 4.8M2018-08-15: 3.8M2018-08-31: 3.8M2018-09-14: 4.5M2018-09-28: 4.1M2018-10-15: 4.2M2018-10-31: 4.2M2018-11-15: 3.9M2018-11-30: 3.7M2018-12-14: 3.5M2018-12-31: 4.3M2019-01-15: 5.4M2019-01-31: 5.0M2019-02-15: 5.1M2019-02-28: 4.8M2019-03-15: 5.0M2019-03-29: 5.1M2019-04-15: 5.4M2019-04-30: 6.0M2019-05-15: 8.0M2019-05-31: 7.4M2019-06-14: 8.1M
the 14 Jun 2019 report24 earlier reportsnormal: 4.4M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Lobbying: Lobbying on a new issue became public on 19 Jul 2019

Chemours lobbying on a new issue.

New
['DEF']
Rule
only points whose every posting (and value revision) is at or before as_of
Field
issue_codes
Metric
lobbying.filings_count
Point id
12653282

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

Timeline

Changes and notable records, by the date each became public

  1. 18 Nov 2026Filings change

    filed a director or officer change: SVP, General Counsel & Corporate Secretary Kristine M. Wellman to retire; Amy M. Rocklin succeeds her Jan 4, 2027.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  2. 18 Nov 2026Filings record

    SVP, General Counsel & Corporate Secretary Kristine M. Wellman to retire; Amy M. Rocklin succeeds her Jan 4, 2027

  3. 14 Aug 2026Insiders record

    Familiar Calderon Gerardo (See Remarks) bought 1,935 shares of CC ($30,051) (dated 13 Aug 2026)

  4. 14 Aug 2026Insiders record

    Dignam Denise (Chief Executive Officer) bought 3,378 shares of CC ($50,501) (dated 13 Aug 2026)

  5. 12 Aug 2026Insiders change

    had 5 insiders buy $408K of its shares on the open market within 30 days (5 filings).

    Who bought: Hostetter Shane, Martinko Joseph T., Foley Michael Robert, Cowan Alister and 1 more.

    See the evidence (5 source records)
    Independent buyers
    5
    Purchase filings (Form 4, code P)
    5
    Total bought
    $408K
    Window
    13 Jul 2026 to 12 Aug 2026

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

  6. 12 Aug 2026Insiders record

    CRANSTON MARY B (director) bought 6,000 shares of CC ($94,980) (dated 11 Aug 2026)

  7. 12 Aug 2026Insiders record

    Cowan Alister (director) bought 13,000 shares of CC ($203,060) (dated 11 Aug 2026)

  8. 12 Aug 2026Insiders record

    Foley Michael Robert (See Remarks) bought 1,934 shares of CC ($30,000) (dated 11 Aug 2026)

  9. 12 Aug 2026Insiders record

    Martinko Joseph T. (See Remarks) bought 1,940 shares of CC ($30,009) (dated 11 Aug 2026)

  10. 11 Aug 2026Insiders record

    HOSTETTER SHANE (Chief Financial Officer) bought 3,350 shares of CC ($50,049) (dated 10 Aug 2026)

  11. 30 Apr 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  12. 30 Apr 2026Filings record

    Director or officer change (dated 29 Apr 2026)

  13. 31 Oct 2025Filings record

    Director or officer change

  14. 29 Aug 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  15. 29 Aug 2025Filings record

    Director or officer change

  16. 27 Aug 2025Short interest and volume change

    had 18.2M shares sold short in the 15 Aug 2025 report, 2.9× the same report last year.

    Same report last year: 6.2M; its normal report is 7.9M.

    See the evidence
    This period
    18.2M (the 15 Aug 2025 report)
    Normal report (median of 24 earlier)
    7.9M
    Typical spread (median absolute deviation)
    1.2M
    How far from its usual level
    +5.9
    Same report last year
    6.2M
    History used
    2,786 days
    2024-08-15: 6.2M2024-08-30: 6.5M2024-09-13: 7.3M2024-09-30: 7.8M2024-10-15: 8.0M2024-10-31: 7.7M2024-11-15: 7.3M2024-11-29: 7.3M2024-12-13: 7.2M2024-12-31: 7.4M2025-01-15: 7.3M2025-01-31: 7.3M2025-02-14: 7.7M2025-02-28: 8.8M2025-03-14: 10.5M2025-03-31: 12.9M2025-04-15: 13.2M2025-04-30: 12.7M2025-05-15: 13.3M2025-05-30: 12.7M2025-06-13: 14.3M2025-06-30: 18.3M2025-07-15: 16.0M2025-07-31: 14.9M2025-08-15: 18.2M
    the 15 Aug 2025 report24 earlier reportsnormal: 7.9M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  17. 14 Aug 2025Institutional holdings change

    saw 69 13F filers open a new position in the quarter ended 30 Jun 2025, 1.3× the same quarter last year.

    Same quarter last year: 53; its normal quarter is 51.

    See the evidence
    This period
    69 (the quarter ended 30 Jun 2025)
    Normal quarter (median of 8 earlier)
    51
    Typical spread (median absolute deviation)
    3
    How far from its usual level
    +3.5
    Same quarter last year
    53
    History used
    3,653 days
    2023-06-30: 492023-09-30: 372023-12-31: 462024-03-31: 492024-06-30: 532024-09-30: 552024-12-31: 532025-03-31: 552025-06-30: 69
    the quarter ended 30 Jun 20258 earlier quartersnormal: 51

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  18. 13 Aug 2025Insiders record

    Dignam Denise (President & CEO) bought 4,068 shares of CC ($49,060) (dated 12 Aug 2025)

  19. 12 Aug 2025Short interest and volume change

    had 14.9M shares sold short in the 31 Jul 2025 report, 2.9× the same report last year.

    Same report last year: 5.2M; its normal report is 7.8M.

    See the evidence
    This period
    14.9M (the 31 Jul 2025 report)
    Normal report (median of 24 earlier)
    7.8M
    Typical spread (median absolute deviation)
    1.2M
    How far from its usual level
    +4.1
    Same report last year
    5.2M
    History used
    2,771 days
    2024-07-31: 5.2M2024-08-15: 6.2M2024-08-30: 6.5M2024-09-13: 7.3M2024-09-30: 7.8M2024-10-15: 8.0M2024-10-31: 7.7M2024-11-15: 7.3M2024-11-29: 7.3M2024-12-13: 7.2M2024-12-31: 7.4M2025-01-15: 7.3M2025-01-31: 7.3M2025-02-14: 7.7M2025-02-28: 8.8M2025-03-14: 10.5M2025-03-31: 12.9M2025-04-15: 13.2M2025-04-30: 12.7M2025-05-15: 13.3M2025-05-30: 12.7M2025-06-13: 14.3M2025-06-30: 18.3M2025-07-15: 16.0M2025-07-31: 14.9M
    the 31 Jul 2025 report24 earlier reportsnormal: 7.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  20. 25 Jul 2025Short interest and volume change

    had 16.0M shares sold short in the 15 Jul 2025 report, 3.2× the same report last year.

    Same report last year: 5.1M; its normal report is 7.7M.

    See the evidence
    This period
    16.0M (the 15 Jul 2025 report)
    Normal report (median of 24 earlier)
    7.7M
    Typical spread (median absolute deviation)
    1.2M
    How far from its usual level
    +4.8
    Same report last year
    5.1M
    History used
    2,755 days
    2024-07-15: 5.1M2024-07-31: 5.2M2024-08-15: 6.2M2024-08-30: 6.5M2024-09-13: 7.3M2024-09-30: 7.8M2024-10-15: 8.0M2024-10-31: 7.7M2024-11-15: 7.3M2024-11-29: 7.3M2024-12-13: 7.2M2024-12-31: 7.4M2025-01-15: 7.3M2025-01-31: 7.3M2025-02-14: 7.7M2025-02-28: 8.8M2025-03-14: 10.5M2025-03-31: 12.9M2025-04-15: 13.2M2025-04-30: 12.7M2025-05-15: 13.3M2025-05-30: 12.7M2025-06-13: 14.3M2025-06-30: 18.3M2025-07-15: 16.0M
    the 15 Jul 2025 report24 earlier reportsnormal: 7.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  21. 26 Jun 2025Short interest and volume change

    had 14.3M shares sold short in the 13 Jun 2025 report, 2.6× the same report last year.

    Same report last year: 5.5M; its normal report is 7.4M.

    See the evidence
    This period
    14.3M (the 13 Jun 2025 report)
    Normal report (median of 24 earlier)
    7.4M
    Typical spread (median absolute deviation)
    1.0M
    How far from its usual level
    +4.7
    Same report last year
    5.5M
    History used
    2,723 days
    2024-06-14: 5.5M2024-06-28: 5.1M2024-07-15: 5.1M2024-07-31: 5.2M2024-08-15: 6.2M2024-08-30: 6.5M2024-09-13: 7.3M2024-09-30: 7.8M2024-10-15: 8.0M2024-10-31: 7.7M2024-11-15: 7.3M2024-11-29: 7.3M2024-12-13: 7.2M2024-12-31: 7.4M2025-01-15: 7.3M2025-01-31: 7.3M2025-02-14: 7.7M2025-02-28: 8.8M2025-03-14: 10.5M2025-03-31: 12.9M2025-04-15: 13.2M2025-04-30: 12.7M2025-05-15: 13.3M2025-05-30: 12.7M2025-06-13: 14.3M
    the 13 Jun 2025 report24 earlier reportsnormal: 7.4M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  22. 11 Jun 2025Short interest and volume change

    had 12.7M shares sold short in the 30 May 2025 report, 2.4× the same report last year.

    Same report last year: 5.4M; its normal report is 7.3M.

    See the evidence
    This period
    12.7M (the 30 May 2025 report)
    Normal report (median of 24 earlier)
    7.3M
    Typical spread (median absolute deviation)
    957K
    How far from its usual level
    +3.8
    Same report last year
    5.4M
    History used
    2,709 days
    2024-05-31: 5.4M2024-06-14: 5.5M2024-06-28: 5.1M2024-07-15: 5.1M2024-07-31: 5.2M2024-08-15: 6.2M2024-08-30: 6.5M2024-09-13: 7.3M2024-09-30: 7.8M2024-10-15: 8.0M2024-10-31: 7.7M2024-11-15: 7.3M2024-11-29: 7.3M2024-12-13: 7.2M2024-12-31: 7.4M2025-01-15: 7.3M2025-01-31: 7.3M2025-02-14: 7.7M2025-02-28: 8.8M2025-03-14: 10.5M2025-03-31: 12.9M2025-04-15: 13.2M2025-04-30: 12.7M2025-05-15: 13.3M2025-05-30: 12.7M
    the 30 May 2025 report24 earlier reportsnormal: 7.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  23. 5 Jun 2025Insiders record

    Gumpel Damian (See Remarks) bought 21,222 shares of CC ($201,377) (dated 4 Jun 2025)

  24. 28 May 2025Short interest and volume change

    had 13.3M shares sold short in the 15 May 2025 report, 2.3× the same report last year.

    Same report last year: 5.9M; its normal report is 7.3M.

    See the evidence
    This period
    13.3M (the 15 May 2025 report)
    Normal report (median of 24 earlier)
    7.3M
    Typical spread (median absolute deviation)
    942K
    How far from its usual level
    +4.3
    Same report last year
    5.9M
    History used
    2,694 days
    2024-05-15: 5.9M2024-05-31: 5.4M2024-06-14: 5.5M2024-06-28: 5.1M2024-07-15: 5.1M2024-07-31: 5.2M2024-08-15: 6.2M2024-08-30: 6.5M2024-09-13: 7.3M2024-09-30: 7.8M2024-10-15: 8.0M2024-10-31: 7.7M2024-11-15: 7.3M2024-11-29: 7.3M2024-12-13: 7.2M2024-12-31: 7.4M2025-01-15: 7.3M2025-01-31: 7.3M2025-02-14: 7.7M2025-02-28: 8.8M2025-03-14: 10.5M2025-03-31: 12.9M2025-04-15: 13.2M2025-04-30: 12.7M2025-05-15: 13.3M
    the 15 May 2025 report24 earlier reportsnormal: 7.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  25. 22 May 2025Insiders record

    HOSTETTER SHANE (Chief Financial Officer) bought 4,450 shares of CC ($50,196) (dated 21 May 2025)

  26. 10 May 2025Short interest and volume change

    had 12.7M shares sold short in the 30 Apr 2025 report, 2.2× the same report last year.

    Same report last year: 5.7M; its normal report is 7.3M.

    See the evidence
    This period
    12.7M (the 30 Apr 2025 report)
    Normal report (median of 24 earlier)
    7.3M
    Typical spread (median absolute deviation)
    932K
    How far from its usual level
    +4.0
    Same report last year
    5.7M
    History used
    2,679 days
    2024-04-30: 5.7M2024-05-15: 5.9M2024-05-31: 5.4M2024-06-14: 5.5M2024-06-28: 5.1M2024-07-15: 5.1M2024-07-31: 5.2M2024-08-15: 6.2M2024-08-30: 6.5M2024-09-13: 7.3M2024-09-30: 7.8M2024-10-15: 8.0M2024-10-31: 7.7M2024-11-15: 7.3M2024-11-29: 7.3M2024-12-13: 7.2M2024-12-31: 7.4M2025-01-15: 7.3M2025-01-31: 7.3M2025-02-14: 7.7M2025-02-28: 8.8M2025-03-14: 10.5M2025-03-31: 12.9M2025-04-15: 13.2M2025-04-30: 12.7M
    the 30 Apr 2025 report24 earlier reportsnormal: 7.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  27. 26 Apr 2025Short interest and volume change

    had 13.2M shares sold short in the 15 Apr 2025 report, 2.5× the same report last year.

    Same report last year: 5.3M; its normal report is 7.3M.

    See the evidence
    This period
    13.2M (the 15 Apr 2025 report)
    Normal report (median of 24 earlier)
    7.3M
    Typical spread (median absolute deviation)
    925K
    How far from its usual level
    +4.3
    Same report last year
    5.3M
    History used
    2,664 days
    2024-04-15: 5.3M2024-04-30: 5.7M2024-05-15: 5.9M2024-05-31: 5.4M2024-06-14: 5.5M2024-06-28: 5.1M2024-07-15: 5.1M2024-07-31: 5.2M2024-08-15: 6.2M2024-08-30: 6.5M2024-09-13: 7.3M2024-09-30: 7.8M2024-10-15: 8.0M2024-10-31: 7.7M2024-11-15: 7.3M2024-11-29: 7.3M2024-12-13: 7.2M2024-12-31: 7.4M2025-01-15: 7.3M2025-01-31: 7.3M2025-02-14: 7.7M2025-02-28: 8.8M2025-03-14: 10.5M2025-03-31: 12.9M2025-04-15: 13.2M
    the 15 Apr 2025 report24 earlier reportsnormal: 7.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  28. 21 Apr 2025several at once

    lobbying on a new issue; it also saw 69 13F filers open a new position in the quarter ended 30 Jun 2025, 1.3× the same quarter last year; and it had 18.2M shares sold short in the 15 Aug 2025 report, 2.9× the same report last year. Three unrelated kinds of activity within 140 days.

    See the evidence (11 changes)

    Short interest and volume: Short interest spike became public on 10 Apr 2025

    Chemours had 12.9M shares sold short in the 31 Mar 2025 report, 2.6× the same report last year.

    This period
    12.9M (the 31 Mar 2025 report)
    Normal report (median of 24 earlier)
    7.2M
    Typical spread (median absolute deviation)
    880K
    How far from its usual level
    +4.3
    Same report last year
    4.9M
    History used
    2,649 days
    2024-03-28: 4.9M2024-04-15: 5.3M2024-04-30: 5.7M2024-05-15: 5.9M2024-05-31: 5.4M2024-06-14: 5.5M2024-06-28: 5.1M2024-07-15: 5.1M2024-07-31: 5.2M2024-08-15: 6.2M2024-08-30: 6.5M2024-09-13: 7.3M2024-09-30: 7.8M2024-10-15: 8.0M2024-10-31: 7.7M2024-11-15: 7.3M2024-11-29: 7.3M2024-12-13: 7.2M2024-12-31: 7.4M2025-01-15: 7.3M2025-01-31: 7.3M2025-02-14: 7.7M2025-02-28: 8.8M2025-03-14: 10.5M2025-03-31: 12.9M
    the 31 Mar 2025 report24 earlier reportsnormal: 7.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Lobbying: Lobbying on a new issue became public on 21 Apr 2025

    Chemours lobbying on a new issue.

    New
    ['CPI']
    Rule
    only points whose every posting (and value revision) is at or before as_of
    Field
    issue_codes
    Metric
    lobbying.filings_count
    Point id
    11559787

    Short interest and volume: Short interest spike became public on 26 Apr 2025

    Chemours had 13.2M shares sold short in the 15 Apr 2025 report, 2.5× the same report last year.

    This period
    13.2M (the 15 Apr 2025 report)
    Normal report (median of 24 earlier)
    7.3M
    Typical spread (median absolute deviation)
    925K
    How far from its usual level
    +4.3
    Same report last year
    5.3M
    History used
    2,664 days
    2024-04-15: 5.3M2024-04-30: 5.7M2024-05-15: 5.9M2024-05-31: 5.4M2024-06-14: 5.5M2024-06-28: 5.1M2024-07-15: 5.1M2024-07-31: 5.2M2024-08-15: 6.2M2024-08-30: 6.5M2024-09-13: 7.3M2024-09-30: 7.8M2024-10-15: 8.0M2024-10-31: 7.7M2024-11-15: 7.3M2024-11-29: 7.3M2024-12-13: 7.2M2024-12-31: 7.4M2025-01-15: 7.3M2025-01-31: 7.3M2025-02-14: 7.7M2025-02-28: 8.8M2025-03-14: 10.5M2025-03-31: 12.9M2025-04-15: 13.2M
    the 15 Apr 2025 report24 earlier reportsnormal: 7.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 10 May 2025

    Chemours had 12.7M shares sold short in the 30 Apr 2025 report, 2.2× the same report last year.

    This period
    12.7M (the 30 Apr 2025 report)
    Normal report (median of 24 earlier)
    7.3M
    Typical spread (median absolute deviation)
    932K
    How far from its usual level
    +4.0
    Same report last year
    5.7M
    History used
    2,679 days
    2024-04-30: 5.7M2024-05-15: 5.9M2024-05-31: 5.4M2024-06-14: 5.5M2024-06-28: 5.1M2024-07-15: 5.1M2024-07-31: 5.2M2024-08-15: 6.2M2024-08-30: 6.5M2024-09-13: 7.3M2024-09-30: 7.8M2024-10-15: 8.0M2024-10-31: 7.7M2024-11-15: 7.3M2024-11-29: 7.3M2024-12-13: 7.2M2024-12-31: 7.4M2025-01-15: 7.3M2025-01-31: 7.3M2025-02-14: 7.7M2025-02-28: 8.8M2025-03-14: 10.5M2025-03-31: 12.9M2025-04-15: 13.2M2025-04-30: 12.7M
    the 30 Apr 2025 report24 earlier reportsnormal: 7.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 28 May 2025

    Chemours had 13.3M shares sold short in the 15 May 2025 report, 2.3× the same report last year.

    This period
    13.3M (the 15 May 2025 report)
    Normal report (median of 24 earlier)
    7.3M
    Typical spread (median absolute deviation)
    942K
    How far from its usual level
    +4.3
    Same report last year
    5.9M
    History used
    2,694 days
    2024-05-15: 5.9M2024-05-31: 5.4M2024-06-14: 5.5M2024-06-28: 5.1M2024-07-15: 5.1M2024-07-31: 5.2M2024-08-15: 6.2M2024-08-30: 6.5M2024-09-13: 7.3M2024-09-30: 7.8M2024-10-15: 8.0M2024-10-31: 7.7M2024-11-15: 7.3M2024-11-29: 7.3M2024-12-13: 7.2M2024-12-31: 7.4M2025-01-15: 7.3M2025-01-31: 7.3M2025-02-14: 7.7M2025-02-28: 8.8M2025-03-14: 10.5M2025-03-31: 12.9M2025-04-15: 13.2M2025-04-30: 12.7M2025-05-15: 13.3M
    the 15 May 2025 report24 earlier reportsnormal: 7.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 11 Jun 2025

    Chemours had 12.7M shares sold short in the 30 May 2025 report, 2.4× the same report last year.

    This period
    12.7M (the 30 May 2025 report)
    Normal report (median of 24 earlier)
    7.3M
    Typical spread (median absolute deviation)
    957K
    How far from its usual level
    +3.8
    Same report last year
    5.4M
    History used
    2,709 days
    2024-05-31: 5.4M2024-06-14: 5.5M2024-06-28: 5.1M2024-07-15: 5.1M2024-07-31: 5.2M2024-08-15: 6.2M2024-08-30: 6.5M2024-09-13: 7.3M2024-09-30: 7.8M2024-10-15: 8.0M2024-10-31: 7.7M2024-11-15: 7.3M2024-11-29: 7.3M2024-12-13: 7.2M2024-12-31: 7.4M2025-01-15: 7.3M2025-01-31: 7.3M2025-02-14: 7.7M2025-02-28: 8.8M2025-03-14: 10.5M2025-03-31: 12.9M2025-04-15: 13.2M2025-04-30: 12.7M2025-05-15: 13.3M2025-05-30: 12.7M
    the 30 May 2025 report24 earlier reportsnormal: 7.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 26 Jun 2025

    Chemours had 14.3M shares sold short in the 13 Jun 2025 report, 2.6× the same report last year.

    This period
    14.3M (the 13 Jun 2025 report)
    Normal report (median of 24 earlier)
    7.4M
    Typical spread (median absolute deviation)
    1.0M
    How far from its usual level
    +4.7
    Same report last year
    5.5M
    History used
    2,723 days
    2024-06-14: 5.5M2024-06-28: 5.1M2024-07-15: 5.1M2024-07-31: 5.2M2024-08-15: 6.2M2024-08-30: 6.5M2024-09-13: 7.3M2024-09-30: 7.8M2024-10-15: 8.0M2024-10-31: 7.7M2024-11-15: 7.3M2024-11-29: 7.3M2024-12-13: 7.2M2024-12-31: 7.4M2025-01-15: 7.3M2025-01-31: 7.3M2025-02-14: 7.7M2025-02-28: 8.8M2025-03-14: 10.5M2025-03-31: 12.9M2025-04-15: 13.2M2025-04-30: 12.7M2025-05-15: 13.3M2025-05-30: 12.7M2025-06-13: 14.3M
    the 13 Jun 2025 report24 earlier reportsnormal: 7.4M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 25 Jul 2025

    Chemours had 16.0M shares sold short in the 15 Jul 2025 report, 3.2× the same report last year.

    This period
    16.0M (the 15 Jul 2025 report)
    Normal report (median of 24 earlier)
    7.7M
    Typical spread (median absolute deviation)
    1.2M
    How far from its usual level
    +4.8
    Same report last year
    5.1M
    History used
    2,755 days
    2024-07-15: 5.1M2024-07-31: 5.2M2024-08-15: 6.2M2024-08-30: 6.5M2024-09-13: 7.3M2024-09-30: 7.8M2024-10-15: 8.0M2024-10-31: 7.7M2024-11-15: 7.3M2024-11-29: 7.3M2024-12-13: 7.2M2024-12-31: 7.4M2025-01-15: 7.3M2025-01-31: 7.3M2025-02-14: 7.7M2025-02-28: 8.8M2025-03-14: 10.5M2025-03-31: 12.9M2025-04-15: 13.2M2025-04-30: 12.7M2025-05-15: 13.3M2025-05-30: 12.7M2025-06-13: 14.3M2025-06-30: 18.3M2025-07-15: 16.0M
    the 15 Jul 2025 report24 earlier reportsnormal: 7.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 12 Aug 2025

    Chemours had 14.9M shares sold short in the 31 Jul 2025 report, 2.9× the same report last year.

    This period
    14.9M (the 31 Jul 2025 report)
    Normal report (median of 24 earlier)
    7.8M
    Typical spread (median absolute deviation)
    1.2M
    How far from its usual level
    +4.1
    Same report last year
    5.2M
    History used
    2,771 days
    2024-07-31: 5.2M2024-08-15: 6.2M2024-08-30: 6.5M2024-09-13: 7.3M2024-09-30: 7.8M2024-10-15: 8.0M2024-10-31: 7.7M2024-11-15: 7.3M2024-11-29: 7.3M2024-12-13: 7.2M2024-12-31: 7.4M2025-01-15: 7.3M2025-01-31: 7.3M2025-02-14: 7.7M2025-02-28: 8.8M2025-03-14: 10.5M2025-03-31: 12.9M2025-04-15: 13.2M2025-04-30: 12.7M2025-05-15: 13.3M2025-05-30: 12.7M2025-06-13: 14.3M2025-06-30: 18.3M2025-07-15: 16.0M2025-07-31: 14.9M
    the 31 Jul 2025 report24 earlier reportsnormal: 7.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Institutional holdings: Many funds opening a new position became public on 14 Aug 2025

    Chemours saw 69 13F filers open a new position in the quarter ended 30 Jun 2025, 1.3× the same quarter last year.

    This period
    69 (the quarter ended 30 Jun 2025)
    Normal quarter (median of 8 earlier)
    51
    Typical spread (median absolute deviation)
    3
    How far from its usual level
    +3.5
    Same quarter last year
    53
    History used
    3,653 days
    2023-06-30: 492023-09-30: 372023-12-31: 462024-03-31: 492024-06-30: 532024-09-30: 552024-12-31: 532025-03-31: 552025-06-30: 69
    the quarter ended 30 Jun 20258 earlier quartersnormal: 51

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

    Short interest and volume: Short interest spike became public on 27 Aug 2025

    Chemours had 18.2M shares sold short in the 15 Aug 2025 report, 2.9× the same report last year.

    This period
    18.2M (the 15 Aug 2025 report)
    Normal report (median of 24 earlier)
    7.9M
    Typical spread (median absolute deviation)
    1.2M
    How far from its usual level
    +5.9
    Same report last year
    6.2M
    History used
    2,786 days
    2024-08-15: 6.2M2024-08-30: 6.5M2024-09-13: 7.3M2024-09-30: 7.8M2024-10-15: 8.0M2024-10-31: 7.7M2024-11-15: 7.3M2024-11-29: 7.3M2024-12-13: 7.2M2024-12-31: 7.4M2025-01-15: 7.3M2025-01-31: 7.3M2025-02-14: 7.7M2025-02-28: 8.8M2025-03-14: 10.5M2025-03-31: 12.9M2025-04-15: 13.2M2025-04-30: 12.7M2025-05-15: 13.3M2025-05-30: 12.7M2025-06-13: 14.3M2025-06-30: 18.3M2025-07-15: 16.0M2025-07-31: 14.9M2025-08-15: 18.2M
    the 15 Aug 2025 report24 earlier reportsnormal: 7.9M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

  29. 21 Apr 2025Lobbying change

    lobbying on a new issue.

    See the evidence
    New
    ['CPI']
    Rule
    only points whose every posting (and value revision) is at or before as_of
    Field
    issue_codes
    Metric
    lobbying.filings_count
    Point id
    11559787
  30. 10 Apr 2025Short interest and volume change

    had 12.9M shares sold short in the 31 Mar 2025 report, 2.6× the same report last year.

    Same report last year: 4.9M; its normal report is 7.2M.

    See the evidence
    This period
    12.9M (the 31 Mar 2025 report)
    Normal report (median of 24 earlier)
    7.2M
    Typical spread (median absolute deviation)
    880K
    How far from its usual level
    +4.3
    Same report last year
    4.9M
    History used
    2,649 days
    2024-03-28: 4.9M2024-04-15: 5.3M2024-04-30: 5.7M2024-05-15: 5.9M2024-05-31: 5.4M2024-06-14: 5.5M2024-06-28: 5.1M2024-07-15: 5.1M2024-07-31: 5.2M2024-08-15: 6.2M2024-08-30: 6.5M2024-09-13: 7.3M2024-09-30: 7.8M2024-10-15: 8.0M2024-10-31: 7.7M2024-11-15: 7.3M2024-11-29: 7.3M2024-12-13: 7.2M2024-12-31: 7.4M2025-01-15: 7.3M2025-01-31: 7.3M2025-02-14: 7.7M2025-02-28: 8.8M2025-03-14: 10.5M2025-03-31: 12.9M
    the 31 Mar 2025 report24 earlier reportsnormal: 7.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  31. 10 Mar 2025Filings record

    Director or officer change

  32. 18 Feb 2025Filings record

    Director or officer change

  33. 11 Feb 2025Filings record

    Director or officer change

  34. 7 Jan 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  35. 7 Jan 2025Filings record

    Director or officer change

  36. 13 Nov 2024Short interest and volume change

    had 7.7M shares sold short in the 31 Oct 2024 report, 1.3× the same report last year.

    Same report last year: 5.8M; its normal report is 5.3M.

    See the evidence
    This period
    7.7M (the 31 Oct 2024 report)
    Normal report (median of 24 earlier)
    5.3M
    Typical spread (median absolute deviation)
    425K
    How far from its usual level
    +3.9
    Same report last year
    5.8M
    History used
    2,498 days
    2023-10-31: 5.8M2023-11-15: 5.4M2023-11-30: 4.8M2023-12-15: 5.0M2023-12-29: 4.8M2024-01-12: 5.2M2024-01-31: 4.9M2024-02-15: 4.6M2024-02-29: 4.7M2024-03-15: 4.9M2024-03-28: 4.9M2024-04-15: 5.3M2024-04-30: 5.7M2024-05-15: 5.9M2024-05-31: 5.4M2024-06-14: 5.5M2024-06-28: 5.1M2024-07-15: 5.1M2024-07-31: 5.2M2024-08-15: 6.2M2024-08-30: 6.5M2024-09-13: 7.3M2024-09-30: 7.8M2024-10-15: 8.0M2024-10-31: 7.7M
    the 31 Oct 2024 report24 earlier reportsnormal: 5.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  37. 25 Oct 2024Short interest and volume change

    had 8.0M shares sold short in the 15 Oct 2024 report, 1.5× the same report last year.

    Same report last year: 5.4M; its normal report is 5.3M.

    See the evidence
    This period
    8.0M (the 15 Oct 2024 report)
    Normal report (median of 24 earlier)
    5.3M
    Typical spread (median absolute deviation)
    395K
    How far from its usual level
    +4.6
    Same report last year
    5.4M
    History used
    2,482 days
    2023-10-13: 5.4M2023-10-31: 5.8M2023-11-15: 5.4M2023-11-30: 4.8M2023-12-15: 5.0M2023-12-29: 4.8M2024-01-12: 5.2M2024-01-31: 4.9M2024-02-15: 4.6M2024-02-29: 4.7M2024-03-15: 4.9M2024-03-28: 4.9M2024-04-15: 5.3M2024-04-30: 5.7M2024-05-15: 5.9M2024-05-31: 5.4M2024-06-14: 5.5M2024-06-28: 5.1M2024-07-15: 5.1M2024-07-31: 5.2M2024-08-15: 6.2M2024-08-30: 6.5M2024-09-13: 7.3M2024-09-30: 7.8M2024-10-15: 8.0M
    the 15 Oct 2024 report24 earlier reportsnormal: 5.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  38. 10 Oct 2024Short interest and volume change

    had 7.8M shares sold short in the 30 Sep 2024 report, 1.6× the same report last year.

    Same report last year: 5.0M; its normal report is 5.2M.

    See the evidence
    This period
    7.8M (the 30 Sep 2024 report)
    Normal report (median of 24 earlier)
    5.2M
    Typical spread (median absolute deviation)
    302K
    How far from its usual level
    +5.0
    Same report last year
    5.0M
    History used
    2,467 days
    2023-09-29: 5.0M2023-10-13: 5.4M2023-10-31: 5.8M2023-11-15: 5.4M2023-11-30: 4.8M2023-12-15: 5.0M2023-12-29: 4.8M2024-01-12: 5.2M2024-01-31: 4.9M2024-02-15: 4.6M2024-02-29: 4.7M2024-03-15: 4.9M2024-03-28: 4.9M2024-04-15: 5.3M2024-04-30: 5.7M2024-05-15: 5.9M2024-05-31: 5.4M2024-06-14: 5.5M2024-06-28: 5.1M2024-07-15: 5.1M2024-07-31: 5.2M2024-08-15: 6.2M2024-08-30: 6.5M2024-09-13: 7.3M2024-09-30: 7.8M
    the 30 Sep 2024 report24 earlier reportsnormal: 5.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  39. 25 Sep 2024Short interest and volume change

    had 7.3M shares sold short in the 13 Sep 2024 report, 1.5× the same report last year.

    Same report last year: 5.0M; its normal report is 5.2M.

    See the evidence
    This period
    7.3M (the 13 Sep 2024 report)
    Normal report (median of 24 earlier)
    5.2M
    Typical spread (median absolute deviation)
    266K
    How far from its usual level
    +4.1
    Same report last year
    5.0M
    History used
    2,450 days
    2023-09-15: 5.0M2023-09-29: 5.0M2023-10-13: 5.4M2023-10-31: 5.8M2023-11-15: 5.4M2023-11-30: 4.8M2023-12-15: 5.0M2023-12-29: 4.8M2024-01-12: 5.2M2024-01-31: 4.9M2024-02-15: 4.6M2024-02-29: 4.7M2024-03-15: 4.9M2024-03-28: 4.9M2024-04-15: 5.3M2024-04-30: 5.7M2024-05-15: 5.9M2024-05-31: 5.4M2024-06-14: 5.5M2024-06-28: 5.1M2024-07-15: 5.1M2024-07-31: 5.2M2024-08-15: 6.2M2024-08-30: 6.5M2024-09-13: 7.3M
    the 13 Sep 2024 report24 earlier reportsnormal: 5.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  40. 25 Jul 2024Filings record

    Director or officer change

Showing the newest 40 of 139 entries; narrow the window or the kind of data to see older ones.

Not listed: 214 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001627223
Ticker
CC
Domain
chemours.com
Employer name
The Chemours Company FC, LLC (1 unverified)
Fein
46-5626518 (1 unverified)
Hq location
DE|WILMINGTON|19801 (1 unverified)
Lobbying client
chemours
Name
2463297 Ontario Limited, Chemours Belgium BVBA, Chemours Deutschland GmbH, Chemours France SAS and 49 more
Uei
HKN1HTXZNYB3
Wikidata
Q20630716
Wikipedia
Chemours
  • DOL H-1B labor condition applications and PERM certifications4 data points9 Mar 2026 to 15 Jun 2026
  • Federal lobbying disclosures (LDA)13 records, 137 data points1 Apr 2015 to 30 Sep 2026
  • SEC Form 13F institutional holdings414 data points30 Jun 2015 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)203 records23 Feb 2016 to 18 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)883 data points31 Dec 2012 to 27 Oct 2026
  • SEC Form 4 insider transactions88 records, 224 data points12 Feb 2016 to 13 Aug 2026
  • FINRA short interest (twice monthly)636 data points29 Dec 2017 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026
  • USASpending.gov federal awards3 data points5 Aug 2022 to 5 Aug 2022
  • Wikipedia pageviews2882 data points1 Jan 2019 to 21 Nov 2026